Group One Trading’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.6M Sell
104,600
-1,200
-1% -$394K 0.06% 330
2025
Q4
$37.1M Buy
105,800
+2,500
+2% +$845K 0.06% 293
2025
Q3
$33.4M Buy
103,300
+54,400
+111% +$16.9M 0.06% 300
2025
Q2
$19M Buy
48,900
+26,200
+115% +$10.5M 0.04% 456
2025
Q1
$9.87M Buy
22,700
+300
+1% +$120K 0.03% 630
2024
Q4
$8.26M Buy
22,400
+11,100
+98% +$4.64M 0.02% 823
2024
Q3
$5.88M Buy
11,300
+3,100
+38% +$1.66M 0.02% 908
2024
Q2
$4.44M Buy
8,200
+6,600
+413% +$3.49M 0.02% 877
2024
Q1
$830K Sell
1,600
-5,600
-78% -$2.79M ﹤0.01% 2254
2023
Q4
$3.4M Sell
7,200
-8,200
-53% -$3.79M 0.01% 1428
2023
Q3
$6.71M Buy
15,400
+1,800
+13% +$816K 0.02% 746
2023
Q2
$6.04M Buy
13,600
+4,200
+45% +$1.94M 0.02% 823
2023
Q1
$4.32M Sell
9,400
-12,300
-57% -$5.85M 0.02% 925
2022
Q4
$11.1M Sell
21,700
-600
-3% -$305K 0.03% 679
2022
Q3
$10.1M Buy
22,300
+9,600
+76% +$4.59M 0.02% 724
2022
Q2
$6.13M Sell
12,700
-2,900
-19% -$1.43M 0.01% 1153
2022
Q1
$7.66M Buy
15,600
+3,300
+27% +$1.51M 0.01% 1191
2021
Q4
$5.7M Sell
12,300
-2,100
-15% -$883K ﹤0.01% 1582
2021
Q3
$5.37M Sell
14,400
-7,100
-33% -$2.7M 0.01% 1610
2021
Q2
$8.21M Sell
21,500
-18,200
-46% -$6.96M 0.01% 1234
2021
Q1
$14.3M Buy
39,700
+4,800
+14% +$1.54M 0.02% 719
2020
Q4
$11.2M Buy
34,900
+1,000
+3% +$307K 0.02% 745
2020
Q3
$9.11M Sell
33,900
-58,800
-63% -$15.8M 0.03% 572
2020
Q2
$24.4M Buy
92,700
+44,600
+93% +$11.9M 0.11% 178
2020
Q1
$10.9M Buy
48,100
+24,500
+104% +$6.68M 0.09% 233
2019
Q4
$7.13M Buy
23,600
+9,100
+63% +$2.5M 0.05% 496
2019
Q3
$3.48M Sell
14,500
-18,600
-56% -$5.1M 0.03% 807
2019
Q2
$9.34M Buy
33,100
+19,100
+136% +$5.22M 0.08% 249
2019
Q1
$4.02M Buy
14,000
+6,900
+97% +$2M 0.04% 540
2018
Q4
$1.86M Sell
7,100
-2,400
-25% -$660K 0.02% 1084
2018
Q3
$2.6M Sell
9,500
-1,200
-11% -$312K 0.02% 972
2018
Q2
$2.55M Buy
10,700
+7,400
+224% +$1.71M 0.02% 959
2018
Q1
$725K Buy
+3,300
New +$775K 0.01% 1752
2017
Q3
Sell
-1,500
Closed -$282K 4902
2017
Q2
$282K Sell
1,500
-100
-6% -$18K ﹤0.01% 2395
2017
Q1
$265K Sell
1,600
-7,500
-82% -$1.19M ﹤0.01% 2320
2016
Q4
$1.31M Buy
+9,100
New +$1.22M 0.01% 1157

Other funds holding ELV

Group One Trading's ELV Position: Q1 2026 in Review

Group One Trading reduced its Elevance Health (ELV) stake by 60% in Q1 2026, selling an estimated $1.32M and leaving 2,707 shares worth $792K. The position accounts for ﹤0.01% of the portfolio, ranked #2924.

Group One Trading first reported a position in ELV in Q2 2017 and has held it in 15 quarters since. The position peaked at $20.3M in Q1 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Group One Trading held 2,707 shares of Elevance Health worth $792K as of Q1 2026.
  • Group One Trading sold 4,031 Elevance Health shares in Q1 2026, an estimated $1.32M.
  • Elevance Health made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #2924 holding.
  • Group One Trading first reported a position in Elevance Health in Q2 2017 and has held it in 15 quarters since.
  • Group One Trading's Elevance Health position peaked at $20.3M in Q1 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.